Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.2058
+0.0048 (2.39%)
At close: Mar 31, 2026, 4:00 PM EDT
0.2020
-0.0038 (-1.85%)
Pre-market: Apr 1, 2026, 8:41 AM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $21.53 million as of April 1, 2026. Its market cap has decreased by -57.17% in one year.
Market Cap
21.53M
Enterprise Value
49.75M
1-Year Change
-57.17%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $21.53M, a decrease of -77.89%. That is a compound annual growth rate of -14.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 21.03M | -79.24% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 23.52M |
| Barinthus Biotherapeutics | 23.24M |
| Vistagen Therapeutics | 22.64M |
| Cue Biopharma | 22.45M |
| Neuphoria Therapeutics | 21.94M |
| Curis | 21.88M |
| Marker Therapeutics | 21.68M |
| Skye Bioscience | 20.51M |